Dissemin is shutting down on January 1st, 2025

Published in

Wiley, Pigment Cell & Melanoma Research, 4(31), p. 534-540, 2018

DOI: 10.1111/pcmr.12694

Links

Tools

Export citation

Search in Google Scholar

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

Journal article published in 2018 by Janice M. Mehnert ORCID, Ann W. Silk, J. H. Lee, Liesel Dudek, Byeong-Seon Jeong, Jiadong Li, Jason M. Schenkel ORCID, Evita Sadimin, Michael Kane, Hongxia Lin, Weichung J. Shih, Andrew Zloza ORCID, Suzie Chen, James S. Goydos ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO